Retatrutide × Licensed Peptides - Lab Test, December 2025
Test results
About this test
This independent HPLC-UV/VIS lab test confirms Retatrutide 15mg from Licensed Peptides at 99.03% total chromatographic purity. The analysis was conducted by a third-party ISO 17025:2017 accredited laboratory and reported on December 12, 2025. The tested quantity measured 16.18 mg against a stated label claim of 15 mg, under Lot No. 102415.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. Endotoxin testing passed at <0.05 EU/mg via the LAL method, and sterility testing via USP <71> confirmed no growth detected.
The full certificate of analysis and HPLC chromatogram are available for review on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.